−0.37USD
−12.66 MUSD
63.05 MUSD
19.60 M
About OREXO AB
Sector
CEO
Nikolaj Sørensen
Headquarters
Uppsala
Website
Employees (FY)
116
Founded
1994
FIGI
BBG00564V5L4
Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. It operates through the following segments: US Pharma, Digital Therapeutics (DTx), and HQ and Pipelines. The US Pharma segment include sales of own pharmaceuticals in the US. The DTx segment comprises digital therapeutic venture. The HQ and Pipeline segment focuses in the out-licensed pharmaceuticals and costs for research and development, business development, global regulatory, and supply chain. The company was founded by Thomas Lundqvist on November 18, 1994 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
